Name: ICD-10 Coordination and Maintenance (C&M) Committee meeting.
Time and Date: 9:00 a.m.-5:00 p.m., March 19-20, 2014.
Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244.
Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. We will be broadcasting the meeting live via Webcast at http://www.cms.gov/live/.
Security Considerations: Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by non-government employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building.
Attendees who wish to attend the March 19-20, 2014 ICD-10-CM C&M meeting must submit their name and organization by March 14, 2014, for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting.
Participants who attended previous Coordination and Maintenance meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you wish attend.
Please register to attend the meeting on-line at: http://www.cms.hhs.gov/apps/events/.
Please contact Mady Hue (410-786-4510 or Marilu.firstname.lastname@example.org), for questions about the registration process.
Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Tenth Revision, Clinical Modification and ICD-10 Procedure Coding System.
Matters To Be Discussed: Tentative agenda items include: March 19-20, 2014.
Administration of Dalbavancinc
Administration of Serelaxin
Implantation of Chemotherapeutic Agent
Number of Coronary Vessels and Stents
Addenda and key updates
ICD-10 MS-DRGs Update
ICD-10-CM Home Health Conversions
ICD-10-CM Diagnosis Topics:
Abnormal level of advanced glycation end products in tissues
Complications of nervous system devices
Complications of urinuary devices
Encounter for newborn, infant and child health examinations
External cause codes for over exertion and repetitive motion
In-Stent Restenosis of Coronary and Peripheral Stent
Necrotizing enterocolitis for non newborns
Observation and evualation of newborns for suspected condition not found
Oral medicine controlled diabetes mellitus
Agenda items are subject to change as priorities dictate.
CMS and NCHS will no longer provide paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS Web sites prior to the meeting at http://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and http://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm
Contact Persons for Additional Information: Donna Pickett, Medical Systems Administrator, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782, email email@example.com, telephone 301-458-4434 (diagnosis); Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Boulevard, Baltimore, Maryland 21244, email firstname.lastname@example.org, telephone 410-786-4510 (procedures).
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2014-03245 Filed 2-13-14; 8:45 am]
BILLING CODE 4160-18-P